Read more
This book presents a comprehensive and comparative study of the patentability of bioprinting inventions, specifically bioinks and bioprinted tissues, in the US, the Europe and Australia. It employs a two-phase analysis to understand, 'Is the patentable subject matter requirement a hurdle to patenting bioprinting inventions, specifically bioinks and bioprinted tissues?' The first phase is a doctrinal analysis of the patent laws and jurisprudence in respective jurisdictions, highlighting the similarities and differences in their approaches to the subject matter requirement. The second phase is an empirical analysis of the patent prosecution data from patent applications filed in each jurisdiction with claims directed towards bioprinted tissues and bioinks, revealing how patent examiners apply the patent provisions to accept or object to such patent claims.
The book offers several contributions to the field of bioprinting and patent law. First, it provides a detailed and up-to-date overview of the current state of the art and the legal landscape of bioprinting inventions. Second, it identifies the main criteria and factors that patent examiners use to assess the patentable subject matter of bioprinted tissues and bioinks, such as the level of human intervention, the markedly different characteristics, and the industrial applicability. Third, it proposes patenting framework models for each jurisdiction, which can assist patent applicants to draft and amend their patent claims in accordance with the patentable subject matter requirement. Fourth, it evaluates the potential benefits and implications of patenting bioprinting inventions for the bioprinting industry and society at large, such as fostering innovation, promoting public health, and indirectly addressing ethical and social issues.
The main benefit that the reader will derive from the book is a deeper understanding of the patentability of bioprinting inventions, specifically bioinks and bioprinted tissues, in different jurisdictions and contexts. The book will help the reader to appreciate the legal and technical aspects of bioprinting and patent law, and how they affect the bioprinting industry and society at large.
List of contents
Introduction.- 3D Bioprinting Innovation: Past, Present and Future.- 3D Bioprinted Tissues and Bioinks: Falling In or Out of the Scope of Subject Matter Requirements of Australian Patent Law.- Are 3D Bioprinted Tissues and Bioinks Patentable Subject Matter in the US?.- Patentable Subject Matter Assessment of 3D Bioprinted Tissues and Bioinks: European Perspective.- Evaluation of Patent Prosecution Data of Patent Applications Claiming 3D Bioprinted Tissues and Bioinks.- Conclusion.
About the author
Dr. Pratap is an Intellectual Property Strategist and Patent researcher. He has expertise in dealing with Intellectual Property issues in relation to emerging technologies such as Artificial intelligence, Synthetic biology, Quantum biotechnology and Climate change. He is a Research fellow at the Faculty of Business, Economics and Law at University of Queensland, Australia. Pratap completed his doctoral studies from the Centre for Law and Genetics, University of Tasmania, Australia. He was invited by Govt. of Japan to assist Japanese Patent Office in harmonizing the Japanese Patent Law in relation AI innovation. He hold a Master of Law (LLM) in Intellectual Property collaboratively offered by the World Intellectual Property Organization (WIPO), Switzerland and the Queensland University of Technology, Australia. He is the recipient of the prestigious International Fellowship offered by WIPO. Pratap was a Visiting fellow at Max Plank Institute of Innovation and Competition, Germany and a Guest faculty at WIPO Academy, Switzerland.
